Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.62 -2.21 (-2.95%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Total Current Liabilities (2010 - 2026)

Updated

Ani Pharmaceuticals' Total Current Liabilities came in at $283.66 million for Q2 2026, up 19.8% from $236.84 million a year earlier and up 18.4% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Ani Pharmaceuticals' Total Current Liabilities was $278.11 million, up 43.0% from FY2024.

  • Total Current Liabilities has increased in each of the last six years, with a five-year compound annual growth rate of 28.8% (FY2020 to FY2025).
  • Going back by year, Total Current Liabilities was $194.45 million in FY2024 (+33.7%), $145.48 million in FY2023 (+46.3%), $99.44 million in FY2022 (+13.6%) and $87.54 million in FY2021 (+11.4%).
  • The Q2 2026 figure represents the highest quarterly Total Current Liabilities in data going back to Q4 2010.
  • Year-over-year, Total Current Liabilities has increased for 15 consecutive quarters, with growth averaging 39.4% over the last eight quarters.
  • The fastest year-over-year change in Total Current Liabilities over five years came in Q2 2025 (growth of 69.2%), and the weakest in Q1 2022 (a decline of 3.9%).
  • Business Quant data shows ANIP's Total Current Liabilities at $239.51 million (Q1 2026), $278.11 million (Q4 2025) and $270.56 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Ani Pharmaceuticals 1.78 Bn 565.34 Mn 165.89 Mn 283.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 283.66 Mn
Mar 31, 2026 239.51 Mn
Dec 31, 2025 278.11 Mn
Sep 30, 2025 270.56 Mn
Jun 30, 2025 236.84 Mn
Mar 31, 2025 201.82 Mn
Dec 31, 2024 194.45 Mn
Sep 30, 2024 189.93 Mn
Jun 30, 2024 139.98 Mn
Mar 31, 2024 136.89 Mn
Dec 31, 2023 145.48 Mn
Sep 30, 2023 134.35 Mn
Jun 30, 2023 122.87 Mn
Mar 31, 2023 125.83 Mn
Dec 31, 2022 99.44 Mn
Sep 30, 2022 81.63 Mn
Jun 30, 2022 96.31 Mn
Mar 31, 2022 79.53 Mn
Dec 31, 2021 87.54 Mn
Sep 30, 2021 84.87 Mn
API Access

Ani Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ANIP&period=max&api_key=YOUR_API_KEY